On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Melanoma Institute Australia

InstitutionResearch output, impact & collaborations

Melanoma Institute Australia is a institution indexed in ScholarIQ from OpenAlex.

What is known about Melanoma Institute Australia?

ScholarIQrecord summary

Melanoma Institute Australia is a research organisation in Sydney, AU. OpenAlex records 3,905 works and 1,056,132 citations for it. 713 researchers list it as their most recent affiliation.

How many works does Melanoma Institute Australia have?

ScholarIQindexed works

Melanoma Institute Australia has 3,905 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Melanoma Institute Australia have?

ScholarIQcitation count

Melanoma Institute Australia has 1,056,132 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Melanoma Institute Australia?

ScholarIQresearcher count

Melanoma Institute Australia has 713 researchers in the ScholarIQ index.

What is the average h-index at Melanoma Institute Australia?

ScholarIQavg h-index

Melanoma Institute Australia has an average h-index of 88.7 in OpenAlex.

What is the ROR of Melanoma Institute Australia?

ScholarIQror

The ROR for Melanoma Institute Australia is on the source record.

What is the OpenAlex record for Melanoma Institute Australia?

ScholarIQopenalex

The OpenAlex for Melanoma Institute Australia is on the source record.

Who are the most-cited researchers behind Melanoma Institute Australia?

ScholarIQtop researchers by citations
1
Richard A. Scolyer · Cutaneous Melanoma Detection and Management
1,733 works107,454 citations
2
Valerie Jakrot · Cancer Genomics and Diagnostics
116 works56,663 citations
3
Jonathan R. Stretch · Cutaneous Melanoma Detection and Management
261 works51,694 citations

What are the most-cited papers on Melanoma Institute Australia?

ScholarIQmost cited works
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
Georgina V. Long, Victoria Atkinson, Serigne Lo, Shahneen Sandhu, Alexander Guminski, Michael P. Brown, James S. Wilmott, Jarem Edwards, Maria Gonzalez, Richard A. Scolyer, Alexander M. Menzies, Grant A. McArthur
The Lancet Oncology. 20181,001 Citations
High response rate to PD-1 blockade in desmoplastic melanomas
Zeynep Eroglu, Jesse M. Zaretsky, Siwen Hu‐Lieskovan, Dae Won Kim, Alain P. Algazi, Douglas B. Johnson, Elizabeth Liniker, Benjamin Y. Kong, Rodrigo Ramella Munhoz, Suthee Rapisuwon, Pier Federico Gherardini, Bartosz Chmielowski, Xiaoyan Wang, I. Peter Shintaku, Cody Wei, Jeffrey A. Sosman, Richard W. Joseph, Michael A. Postow, Matteo S. Carlino, Wen-Jen Hwu, Richard A. Scolyer, Jane L. Messina, Alistair J. Cochran, Georgina V. Long, Antoni Ribas
Nature. 2018333 CitationsOPEN ACCESS
The Impact of In Vivo Reflectance Confocal Microscopy on the Diagnostic Accuracy of Lentigo Maligna and Equivocal Pigmented and Nonpigmented Macules of the Face
Pascale Guitera, Giovanni Pellacani, Kerry A. Crotty, Richard A. Scolyer, Ling-Xi L. Li, Sara Bassoli, Marco Vinceti, Harold Rabinovitz, Caterina Longo, Scott W. Menzies
Journal of Investigative Dermatology. 2010302 CitationsOPEN ACCESS

Who collaborates most closely around Melanoma Institute Australia?

ScholarIQco-authorship network
United States
100%

How much of the research on Melanoma Institute Australia is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
0%
Bronze
33%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial